Rhythm Pharmaceuticals Statistics
Total Valuation
RYTM has a market cap or net worth of $6.21 billion. The enterprise value is $5.98 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RYTM has 68.53 million shares outstanding. The number of shares has increased by 7.27% in one year.
| Current Share Class | 68.53M |
| Shares Outstanding | 68.53M |
| Shares Change (YoY) | +7.27% |
| Shares Change (QoQ) | +1.64% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 90.56% |
| Float | 55.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.59 |
| Forward PS | 18.24 |
| PB Ratio | 48.57 |
| P/TBV Ratio | 52.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.17, with a Debt / Equity ratio of 0.47.
| Current Ratio | 4.17 |
| Quick Ratio | 3.63 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.99 |
Financial Efficiency
Return on equity (ROE) is -101.16% and return on invested capital (ROIC) is -39.37%.
| Return on Equity (ROE) | -101.16% |
| Return on Assets (ROA) | -29.76% |
| Return on Invested Capital (ROIC) | -39.37% |
| Return on Capital Employed (ROCE) | -58.20% |
| Weighted Average Cost of Capital (WACC) | 14.89% |
| Revenue Per Employee | $524,553 |
| Profits Per Employee | -$502,029 |
| Employee Count | 414 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 0.96 |
Taxes
In the past 12 months, RYTM has paid $962,000 in taxes.
| Income Tax | 962,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.03% in the last 52 weeks. The beta is 1.94, so RYTM's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | +48.03% |
| 50-Day Moving Average | 87.13 |
| 200-Day Moving Average | 98.67 |
| Relative Strength Index (RSI) | 52.77 |
| Average Volume (20 Days) | 766,457 |
Short Selling Information
The latest short interest is 8.06 million, so 11.76% of the outstanding shares have been sold short.
| Short Interest | 8.06M |
| Short Previous Month | 7.83M |
| Short % of Shares Out | 11.76% |
| Short % of Float | 14.47% |
| Short Ratio (days to cover) | 11.88 |
Income Statement
In the last 12 months, RYTM had revenue of $217.17 million and -$207.84 million in losses. Loss per share was -$3.14.
| Revenue | 217.17M |
| Gross Profit | 194.16M |
| Operating Income | -197.37M |
| Pretax Income | -201.72M |
| Net Income | -207.84M |
| EBITDA | -196.17M |
| EBIT | -197.37M |
| Loss Per Share | -$3.14 |
Full Income StatementBalance Sheet
The company has $340.63 million in cash and $112.31 million in debt, with a net cash position of $228.32 million or $3.33 per share.
| Cash & Cash Equivalents | 340.63M |
| Total Debt | 112.31M |
| Net Cash | 228.32M |
| Net Cash Per Share | $3.33 |
| Equity (Book Value) | 237.62M |
| Book Value Per Share | 1.80 |
| Working Capital | 326.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$119.51 million and capital expenditures -$953,000, giving a free cash flow of -$120.46 million.
| Operating Cash Flow | -119.51M |
| Capital Expenditures | -953,000 |
| Depreciation & Amortization | 1.21M |
| Net Borrowing | n/a |
| Free Cash Flow | -120.46M |
| FCF Per Share | -$1.76 |
Full Cash Flow StatementMargins
Gross margin is 89.41%, with operating and profit margins of -90.89% and -93.33%.
| Gross Margin | 89.41% |
| Operating Margin | -90.89% |
| Pretax Margin | -92.89% |
| Profit Margin | -93.33% |
| EBITDA Margin | -90.33% |
| EBIT Margin | -90.89% |
| FCF Margin | n/a |
Dividends & Yields
RYTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.27% |
| Shareholder Yield | -7.27% |
| Earnings Yield | -3.35% |
| FCF Yield | -1.94% |
Analyst Forecast
The average price target for RYTM is $138.20, which is 52.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $138.20 |
| Price Target Difference | 52.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 41.32% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RYTM has an Altman Z-Score of 12.79 and a Piotroski F-Score of 4.
| Altman Z-Score | 12.79 |
| Piotroski F-Score | 4 |
